Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.
about
Androgen actions on endothelium functions and cardiovascular diseasesDehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen.Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptorHormonal modulation of endothelial NO production.Time-dependent effect of orchidectomy on vascular nitric oxide and thromboxane A2 release. Functional implications to control cell proliferation through activation of the epidermal growth factor receptor.Androgen receptor in human endothelial cells.Endothelial function as measured by peripheral arterial tonometry increases during pubertal advancement.Androgens and esophageal cancer: What do we know?Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanismsThe use of hormones indicators in human saliva in diagnosing parodontitis in pregnant women.Estrogen Regulation of Fetal Adrenal Cortical Zone-Specific Development in the Nonhuman Primate Impacts Adrenal Production of Androgen and Cortisol and Response to ACTH in Females in Adulthood.Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion.Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels.A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?Gender, sex hormones and pulmonary hypertension.Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.Endothelial dysfunction: a potential tool in gender related cardiovascular disease.Androgen replacement therapy and cardiovascular function.DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence.Why sex matters: the biological mechanisms of cardiovascular disease.Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.Androgen therapy in women: for whom and when.Dehydroepiandrosterone (DHEA): hypes and hopes.Neurosteroids in clinical practice: implications for women's health.Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism.Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo.Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats.Stimulation of sigma-1 receptor signaling by dehydroepiandrosterone ameliorates pressure overload-induced hypertrophy and dysfunctions in ovariectomized rats.Mechanism of salutary effects of androstenediol on hepatic function after trauma-hemorrhage: role of endothelial and inducible nitric oxide synthase.Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone.Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells.Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements.Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry.Persistent high activity of the fetal adrenal cortex in preterm infants: is there a clinical significance?
P2860
Q26750657-16BA0319-426E-46C8-9868-81D556D5C6A2Q33552190-ABC2D1DD-3F8E-4130-B65A-B91B76BEC205Q33820667-1219C9B8-47D2-4C5F-BFF1-699436B982F9Q33833608-42600AAA-1620-46E0-B512-A7124FDEF7D2Q33889986-A1613D7F-BBB4-415D-9A48-7800FE956183Q34042948-5E5EE6A4-625D-43CD-B5A0-7B0896C7448FQ35574166-317E53DF-C27B-48B1-A4FA-168D03EE8500Q35651459-7FAB33E4-4A01-4414-BF43-14F285179C39Q35946199-4FDDC7B1-0D31-4734-8C4D-CF6CDDD09203Q36509791-3DA18908-3836-48A4-A2C0-15EAC8539851Q36851073-5C0C3703-6660-4A4A-96FD-E672300DFEFCQ36911634-716A2743-C561-49F7-B4AC-33007246BBFDQ36944784-8632EF91-6FF4-45E4-8FE1-356C664C58D7Q36974411-8678BB77-2EFD-4D7F-9835-5415E5ED9C29Q37102070-999C344F-B8D6-4E2F-BFEA-9F6BF2A0EB07Q37133789-9EA50554-7149-4066-83EA-76E8371E59BAQ37351248-8353B152-7206-4408-BA0D-D13754AC26BDQ37362719-F830EBF8-1A40-4A91-8EBD-C0B9153F6531Q37610408-F9775DA0-2DA6-457C-ABD2-B10A2F8F945BQ37764342-02A78F25-8077-4330-AD81-0FC690916DCEQ37983641-F60E5CD5-FA46-486C-ADBB-C8FA83BAD7A0Q38095223-814DCAEB-2497-47C7-9324-0B2F361FEDDAQ38126357-C2FC25A1-E3B9-4683-9632-E28772C3915FQ38229306-5281FABC-F34E-4853-90E4-FD94A8CE8241Q38471653-92D8020C-0C10-4269-9D32-03D452CEDEB9Q41549578-0BBD0960-4917-42E2-82B6-DBBB660A3B07Q42923084-1E73D360-A666-4F8C-BFE3-CEA4ADCE07F1Q43023689-1E3DCF39-5B10-47A1-92F6-F69F4E78D27BQ43093122-7F7DAFF1-CA82-4241-BE07-3B546A0F11D9Q43273567-8B1F8618-0E9A-4D90-A939-5F9E6C7E2618Q45075423-68F85851-BBFC-418F-81B2-72FA226A4A5EQ45214439-0A168504-ED4E-400D-B950-0F0F7E716E8BQ45229032-7177C17B-AD4D-4DD5-BE5F-C2D4C656BD5CQ45235670-5959F5A5-DAC9-496A-8C0E-3959A73D0567Q45239805-094FC2A1-6F97-4415-AB81-FBDB067D99BBQ46701075-77F4F1FD-0EE0-4645-B368-926523389CB7Q46951277-CDBD78F9-1DFE-4AC6-AA9E-446F5A39ADDEQ48173526-CFA00D3C-DD36-45B4-9103-21237F37F934Q48465787-C3256206-D87D-4D10-8447-EEBF839E0488Q51770594-BBD2AD52-9B22-4D4D-9E50-C6934E3DC12D
P2860
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@en
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@nl
type
label
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@en
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@nl
prefLabel
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@en
Dehydroepiandrosterone modulat ...... mic and nongenomic mechanisms.
@nl
P2093
P356
P1433
P1476
Dehydroepiandrosterone modulat ...... omic and nongenomic mechanisms
@en
P2093
Andrea R Genazzani
Antonella Caruso
Gaetano Varone
Letizia Fornari
P304
P356
10.1210/EN.2003-0044
P407
P577
2003-08-01T00:00:00Z